Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rocuronium effects on hypoxic ventilatory response in obstructive sleep apnea before and after CPAP
2011-005792-16Phase 4Active
- Sponsor
- Karolinska University Hospital
- Start
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of rocuronium, sponsored by Karolinska University Hospital. Primary endpoint: Hypoxic ventilatory response. Started Jan 2012; status: active.
02
Drugs
rocuronium
Beyond the preview
Go deeper on 2011-005792-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005792-16.